Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
Department of Gastroenterology, Landspitali University Hospital, Reykjavik, Iceland.
Scand J Gastroenterol. 2020 Apr;55(4):472-478. doi: 10.1080/00365521.2020.1743751. Epub 2020 Apr 1.
Abstinence from alcohol is recommended in patients diagnosed with alcoholic hepatitis (AH) and alcoholic cirrhosis (AC). We aimed to determine the impact of alcohol abstinence on prognosis of patients with AC and AH. All incident AC and AH patients in Iceland 2001-2016 were identified. Cirrhosis was confirmed clinically, biochemically, with imaging and histologically. Abstinence, alcohol rehabilitation and survival were analyzed. Overall, 169 patients with AC and/or AH were identified. Eleven died during index hospitalization, leaving 158 patients for final analysis, median (IQR) age 56 years (48-65), 72% males. Over all 61 patients (39%) had AC, 40 (25%) AH and 57 (36%) features of both. Thirty-nine percent of patients remained abstinent during follow-up and 63% underwent alcohol rehabilitation. Moderate to severe ascites at diagnosis (odds ratio (OR): 3.05, 95% confidence interval (CI): 1.37-7.02) and lack of alcoholic rehabilitation (OR: 5.28, 95% CI: 2.24- 14.11) were independent predictors of abstinence. Abstinence at one year of follow-up was not related to increased survival. Patients surviving one year, abstinence during follow-up was related to increased survival for both groups. Abstinence from alcohol following AC/AH diagnosis was achieved in 39% of patients. Abstinence was not related to increased survival for alcoholic liver disease patients at one-year, which might partly indicate that this might be a marker that some patients were 'too sick to drink'. AC and AH patients who survived one year and remained abstinent had a favorable long-term prognosis.
建议患有酒精性肝炎 (AH) 和酒精性肝硬化 (AC) 的患者戒酒。我们旨在确定戒酒对 AC 和 AH 患者预后的影响。确定了 2001-2016 年冰岛所有新诊断的 AC 和 AH 患者。通过临床、生化、影像学和组织学确认肝硬化。分析了戒酒、酒精康复和生存情况。共确定了 169 例 AC 和/或 AH 患者。11 例患者在住院期间死亡,最终对 158 例患者进行了分析,中位(IQR)年龄为 56 岁(48-65),男性占 72%。所有患者中,61 例(39%)有 AC,40 例(25%)有 AH,57 例(36%)兼有两者特征。39%的患者在随访期间保持戒酒,63%的患者接受了酒精康复治疗。诊断时有中重度腹水(比值比(OR):3.05,95%置信区间(CI):1.37-7.02)和缺乏酒精康复(OR:5.28,95% CI:2.24-14.11)是戒酒的独立预测因素。随访 1 年时的戒酒与生存率增加无关。存活 1 年的患者,随访期间戒酒与两组生存率增加有关。在 AC/AH 诊断后,有 39%的患者戒酒。对于酒精性肝病患者,戒酒 1 年与生存率增加无关,这可能部分表明这可能是一些患者“病得太重而无法饮酒”的标志。存活 1 年且保持戒酒的 AC 和 AH 患者具有良好的长期预后。